V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192000 | 20123821 | 1.52 | 86 | null | 2021-11-03 | 2021-11-12 | Docetaxel | 02 | null | DOCETAXEL | 101324868 |
| 20192001 | 20123822 | null | 65 | Palliative (P) | 2017-12-24 | 2017-12-30 | Cetuximab + FOLFIRI cycle 2 onwards | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100018784 |
| 20192014 | 20123823 | 1.55 | 82.6 | Palliative (P) | 2016-06-11 | 2016-07-10 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100282856 |
| 20192015 | 20123824 | 1.6 | 76.6 | null | 2020-01-16 | 2020-01-17 | Docetaxel | 02 | null | DOCETAXEL | 101139376 |
| 20192016 | 20123825 | 1.85 | 58.8 | null | 2017-05-10 | 2017-05-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101607177 |
| 20192020 | 20123826 | 1.66 | 65.2 | null | 2018-09-14 | 2018-09-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100411137 |
| 20192033 | 20123827 | 1.89 | 76 | null | 2019-10-08 | 2019-10-19 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100070024 |
| 20192035 | 20123828 | 1.7 | 71.4 | null | 2016-03-03 | 2016-11-27 | Docetaxel | 02 | null | DOCETAXEL | 100354234 |
| 20192040 | 20123829 | 1.7 | 63.9 | Palliative (P) | 2018-07-02 | 2018-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100820931 |
| 20192041 | 20123830 | 1.7 | 50.4 | Palliative (P) | 2020-07-02 | 2020-07-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100270350 |
| 20192044 | 20123831 | 1.84 | 78 | Palliative (P) | 2019-06-25 | 2019-07-07 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100011945 |
| 20192048 | 20123832 | 1.5 | 68.85 | Palliative (P) | 2018-09-02 | 2018-09-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101841478 |
| 20192049 | 20123833 | 1.66 | 58 | Palliative (P) | 2020-01-09 | 2020-01-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100636163 |
| 20192050 | 20123834 | 1.66 | 75.95 | Palliative (P) | 2017-10-09 | 2017-12-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101700088 |
| 20192053 | 20123835 | null | 37.9 | Palliative (P) | 2019-04-28 | 2019-05-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101473901 |
| 20192054 | 20123836 | 1.66 | 124 | Curative (C) | 2019-10-04 | 2019-10-17 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100505775 |
| 20192055 | 20123837 | 1.63 | 65.4 | Palliative (P) | 2017-06-22 | 2017-06-24 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101609451 |
| 20192059 | 20123838 | 1.36 | 49.1 | Palliative (P) | 2018-05-27 | 2018-08-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100772680 |
| 20192062 | 20123839 | 1.81 | 84.2 | Adjuvant (A) | 2018-02-02 | 2018-02-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100095002 |
| 20192063 | 20123840 | 1.55 | 65 | null | 2020-01-20 | 2020-01-20 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101572636 |
| 20192065 | 20123841 | 1.81 | 58 | null | 2019-02-15 | 2019-05-17 | Docetaxel | 02 | null | DOCETAXEL | 101017400 |
| 20192066 | 20123842 | 1.76 | 98 | Palliative (P) | 2017-12-03 | 2018-04-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101633474 |
| 20192067 | 20123843 | 0 | 61.5 | Palliative (P) | 2019-07-08 | 2019-07-23 | Docetaxel | 02 | N | DOCETAXEL | 100909226 |
| 20192076 | 20123844 | 1.84 | 72 | Palliative (P) | 2016-11-29 | 2016-12-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101742136 |
| 20192080 | 20123845 | 1.66 | 72.4 | Palliative (P) | 2019-03-27 | 2019-04-17 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100313924 |
| 20192088 | 20123846 | 1.67 | 78 | Palliative (P) | null | 2016-09-26 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100400219 |
| 20192091 | 20123847 | 0 | 72.6 | null | 2021-02-16 | 2021-02-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101235776 |
| 20192093 | 20123848 | 1.72 | 55.4 | null | 2019-12-17 | 2019-12-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100606932 |
| 20192096 | 20123849 | 1.68 | 92 | Palliative (P) | 2017-03-22 | 2017-03-22 | Docetaxel | 02 | N | DOCETAXEL | 101016490 |
| 20192097 | 20123850 | 1.69 | 63 | Palliative (P) | 2020-05-02 | 2020-05-20 | Docetaxel | 02 | N | DOCETAXEL | 101179210 |
| 20192104 | 20123851 | 1.77 | 86.4 | Neo-adjuvant (N) | 2018-12-13 | 2018-12-24 | Cetuximab + FOLFIRI cycle1 | 02 | null | DOCETAXEL | 101607399 |
| 20192107 | 20123852 | 1.5 | 66.7 | null | 2019-12-25 | 2020-01-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101597994 |
| 20192110 | 20123853 | 1.66 | 74.4 | Palliative (P) | 2019-03-29 | 2019-03-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101227060 |
| 20192112 | 20123854 | 1.77 | 76.6 | null | 2016-09-18 | 2016-09-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100086313 |
| 20192116 | 20123855 | 1.66 | 68.7 | Palliative (P) | 2018-10-20 | 2020-12-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100571284 |
| 20192118 | 20123856 | 1.68 | 56.1 | Palliative (P) | 2017-04-04 | 2017-04-04 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100725995 |
| 20192122 | 20123857 | 1.83 | 71.3 | null | 2019-10-15 | 2020-01-02 | Docetaxel | 02 | null | DOCETAXEL | 101548433 |
| 20192124 | 20123858 | 1.7 | 82 | Palliative (P) | 2017-09-08 | 2017-09-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100379337 |
| 20192125 | 20123859 | 1.9 | 72 | Palliative (P) | 2017-08-06 | 2017-08-23 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100047667 |
| 20192129 | 20123860 | 1.61 | 76 | Palliative (P) | 2018-01-29 | 2018-01-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100865611 |
| 20192131 | 20123861 | 1.65 | 57.3 | Palliative (P) | 2019-10-31 | 2019-11-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101686884 |
| 20192135 | 20123862 | 1.68 | 81.2 | Palliative (P) | 2018-01-05 | 2018-03-02 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100210410 |
| 20192140 | 20123863 | 1.63 | 64 | null | 2016-04-10 | 2017-04-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101102384 |
| 20192142 | 20123864 | 1.69 | 73 | Palliative (P) | 2019-03-25 | 2019-03-25 | CETUXIMAB + IRINOTECAN + MDG | null | N | CAPECITABINE + GEMCITABINE | 100880469 |
| 20192143 | 20123865 | 1.62 | 80 | Palliative (P) | 2019-06-11 | 2019-06-20 | Docetaxel | 02 | N | DOCETAXEL | 100232924 |
| 20192145 | 20123866 | 1.9 | 75 | Palliative (P) | 2021-01-03 | 2021-01-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100792929 |
| 20192147 | 20123867 | 1.85 | 67.2 | Palliative (P) | 2016-06-05 | 2016-06-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100136413 |
| 20192149 | 20123868 | 1.63 | 63.8 | Palliative (P) | 2016-07-05 | 2016-07-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100286976 |
| 20192152 | 20123869 | 1.77 | 94.4 | null | 2017-06-25 | 2017-06-25 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101120460 |
| 20192154 | 20123870 | 1.72 | 70.3 | null | 2015-09-26 | 2016-07-31 | Docetaxel | null | null | DOCETAXEL | 101556649 |